Oral anti-Xa anticoagulation after Trans-Aortic Valve Implantation for Aortic Stenosis: The randomized ATLANTIS trial
Conclusions ATLANTIS tests the superiority of an apixaban-based strategy versus the recommended standard of care strategy to reduce the risk of post-TAVR thromboembolic and bleeding complications in an all comer population.
Source: American Heart Journal - Category: Cardiology Source Type: research
More News: Academia | Aortic Stenosis | Aspirin | Atrial Fibrillation | Bleeding | Cardiology | Heart | Heart Attack | Heart Valve Surgery | Pulmonary Thromboembolism | Stroke | Study | Thrombosis | Vitamin K | Vitamins